Goldstein N, Bockstal V, Bart S, Luhn K, et al. Safety and Immunogenicity of Heterologous and Homologous Two Dose Regimens of Ad26- and MVA-Vectored Ebola Vaccines: A Randomized, Controlled Phase 1 Study. J Infect Dis 2020 Sep 16. pii: 5906668. doi: 10.1093.
PMID: 32939546